Abacavir |
|
| Synonyms: (1S,4R)-4-[2-Amino-6-(cyclopropylamino)-9H-purin-9-yl]-2-cyclopentene-1-methanol | |
| Cat. No.: A00001 | CAS No.: 136470-78-5 |
| MDL.: | Formula: C14H18N6O |
| F.W.286.33 | Purity: 99％ |
| Storage: Refrigerator | |
| Size/Unit | Price | Qty | Availability | Price Total |
|---|---|---|---|---|
| 25mg | $75.00 | Enter qty and click checkbox |
 
|
$75.00 |
| Catalog Number： | A00001 | CAS No.: | 136470-78-5 | |
| MDL: | Formula: | C14H18N6O | ||
| F.W.: | 286.33 | Purity: | 99％ | |
| Package: | Unit: | |||
| Appearance: | White solid foam from acetonitrile | M.P.: | 165° | |
| B.P.: | Density: | |||
| Optical Rotation: | Refractive Index: | |||
| Solubility: | Stability: | |||
| Storage: | Refrigerator | Category: | Reference Standard | |
| Reference: | Nucleoside reverse transcriptase inhibitor (NRTI). Prepn: S. M. Daluge, EP 349242 (1990 to Wellcome Found.); idem, US 5034394 (1991 to Burroughs Wellcome). Asymmetric synthesis: M. T. Crimmins, B. W. King, J. Org. Chem. 61, 4192 (1996). Pharmacology and biological profile: S. M. Daluge et al., Antimicrob. Agents Chemother. 41, 1082 (1997). Review of antiviral activity and clinical evaluations: R. H. Foster, D. Faulds, Drugs 55, 729-736 (1998). Clinical trial of triple nucleoside regimen in HIV patients: S. Staszewski et al., J. Am. Med. Assoc. 285, 1155 (2001). | |||
| Application: | A nucleoside reverse transcriptase inhibitor (NRTI). Inhibitors | |||
| Category: | Antiviral | |||